Clinical research - Press Releases

Date	Title	Company
24-Dec-2021	Amerigo Scientific Launches KCC2 Ion Channel for Researchers	Amerigo Scientific
24-Dec-2021	STEMart Announces Sensitization Testing for Medical Device	STEMart
24-Dec-2021	CD Bioparticles Announces Offering of Polylactides for Researchers	CD Bioparticles
24-Dec-2021	CD Bioparticles Launches New Polystyrene Latex Beads to Accelerate Bioresearch	CD Bioparticles
23-Dec-2021	Creative Diagnostics Launches Immunohistochemistry Antibodies for Pathology Study	Creative Diagnostics
22-Dec-2021	IoM Hospice and digital health company leading clinical study to inform global dementia care	Memory Lane Games
21-Dec-2021	ProBioGen's GlymaxX® Technology Reaches Phase III Clinical Development	ProBioGen
20-Dec-2021	Advancing AI Drug Discovery in Clinical Trials at SMi’s 3rd Annual AI in Drug Discovery Conference	SMi Group
20-Dec-2021	SMi’s 10th Annual Pharmaceutical Microbiology UK Conference - A Virtual Conference with Online Access Only	SMi Group
16-Dec-2021	North-South MedTech Summit features healthcare and technology speakers across the UK	Empact Ventures
15-Dec-2021	Panthera leads the way in the UK with specialist research sites for NASH and NAFLD studies	Panthera Biopartners
15-Dec-2021	HUTCHMED Highlights HMPL-523 Clinical Data Presented at the 2021 ASH Annual Meeting	HUTCHMED
15-Dec-2021	Actimed Therapeutics Achieves Major Corporate Milestone - Initiation of first clinical study of new salt of S-pindolol (ACM-001.1)	Actimed Therapeutics
15-Dec-2021	Data from two Phase 3 studies demonstrating fitusiran significantly reduced bleeds in people with hemophilia A or B, with or without inhibitors, were featured at ASH’s plenary and late-breaking sessions	Sanofi
15-Dec-2021	Egetis intends to submit a marketing authorisation application for Emcitate® to the European Medicines Agency based on existing clinical data	Egetis Therapeutics AB
15-Dec-2021	Idorsia to further characterize lucerastat for the treatment of Fabry disease by continuing the open-label extension of the Phase 3 MODIFY study	Idorsia
15-Dec-2021	EQT Private Equity and Goldman Sachs Asset Management Complete Acquisition of Parexel	Parexel
14-Dec-2021	HUTCHMED Highlights Surufatinib and Toripalimab Combination Clinical Data being Presented at the ESMO Immuno-Oncology 2021 Meeting	HUTCHMED
10-Dec-2021	IDDI celebrates its 30th anniversary this year	IDDI
09-Dec-2021	New England Journal of Medicine publishes positive Phase 3 Dupixent® (dupilumab) results in children with moderate-to-severe asthma	New England Journal of Medicine